European Biotech Acquisition Corp.

European Biotech Acquisition Corp. (Nasdaq: EBAC) is a blank-check company incorporated to pursue a business combination with one or more businesses operating in the European biotechnology and life sciences sector. The company went public in 2021 and filed a Form 10-Q with the SEC on June 22, 2021, under accession number 0001193125-21-196340, marking its active search phase for a target. EBAC is positioned at the intersection of transatlantic capital markets and the European life sciences ecosystem, seeking to bring a European biotech company to U.S. public markets. Visit SpacDesk and sign up for full filing history, sponsor details, and real-time deal-status tracking on EBAC and hundreds of other SPACs.